glp-1 and gip receptor agonist GLP-1/GIP Agonists Diabetic Retinopathy: What ODs Should Know Corrination of a GLP-1 Receptor
Description
In our experience, transitioning directly to subcutaneous semaglutide 1 mg once weekly from another GLP-1 receptor agonist can be associated with nausea or GI disturbance

Potential adverse effects, such as gastrointestinal issues and long-term safety concerns, also limit widespread adoption

Combining physical activity with a balanced diet is recommended for maximum weight management effectiveness

Youll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!

Bold font = the HR was significantly different from 1.00
